Vocal Biomarkers Market Scope
Growing adoption of a minimally invasive procedure for diagnosis and increasing occurrence of neurological and psychological disorders will help boost global Vocal-biomarkers market in the forecasted period. Vocal-biomarkers is a method that allows machines to understand human emotions by examining, recording and identifying raw voice intonations as persons speak. It uses voice-input to deliver diagnosis and insight into the health situations of an individual. Several features of a personís voice can help analyze the physical as well as the welfare of the person.
The market study is being classified by Type (Amplitude, Error rate, Frequency, Vocal rise or fall time, Voice tremor, Pitch and Others) and major geographies with country level break-up. According to AMA, the Global Vocal Biomarkers market is expected to see growth rate of 14.4% and may see market size of USD2.61 Billion by 2024.
The Players having a strong hold in the market are Beyond Verbal Communication, Sonde Health, PeakProfiling, IBM Corporation and Cogito Corporation. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Vocal Biomarkers market throughout the predicted period.
Beyond Verbal Communication Ltd. (Israel), Sonde Health, Inc. (United States), PeakProfiling GmbH (Germany), IBM Corporation (United States), Cogito Corporation (United States), Microtest Health Ltd. (United Kingdom), Boston Technology Corporation (United States), conversationHEALTH (Canada), Meditech Electronic GmbH (Germany) and Orbita, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Puretech Health (United States) and WinterLight Labs Inc. (Canada).
AdvanceMarketAnalytics has segmented the market of Global Vocal Biomarkers market by Type, Application and Region.
On the basis of geography, the market of Vocal Biomarkers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North Amercia region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Indication, the sub-segment i.e. Psychiatric Disorders will boost the Vocal Biomarkers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals and Clinics will boost the Vocal Biomarkers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On February 13, 2019, IBM Watson Health and the Broad Institute of MIT and Harvard are expanding their partnership to help clinicians better predict the possibility of serious cardiovascular diseases. By working with genomics, clinical data and AI, IBM and the Broad Institute hope this three-year project will help provide doctors with tools to tap into the potential of genomics data, and better understand the intrinsic possibility an individual has for a certain disease. Equipped with this knowledge, health professionals can potentially intervene and help to reduce this risk.
- Upsurging Adoption of Minimally Invasive Surgeries for Diagnosis
- Robust Research and Developments on Enhancing Respective Treatments
- Growing Prevalence of Neurological and Psychological Disorders
- Increasing Instances of Depression, Attention Deficit and Disruptive Behavior Disorders
- Continuously Growing Healthcare Infrastructure across the Globe
- Upsurging Opportunities in Preventive Healthcare Treatments and Remote Patient Monitoring
- Comparatively Higher Costs Associated with Vocal Biomarkers
- Technical Issues related to Accuracy and Electronics Components
- Increasing Diagnosis Complexities Negligible Tolerance Level
- Lack of Skilled Workforce
Key Target AudienceGlobal Vocal biomarkers, manufacturers & suppliers, Research and development (R&D) companies, Market research and consulting service providers, Academic institutes and universities, Government Agencies and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase